CWM
BIIB icon

Consultiva Wealth Management’s Biogen BIIB Stock Holding History

Consultiva Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.4K Hold
25
– – 0.01% 244
2026
Q1 		$4.58K Hold
25
– – 0.01% 231
2025
Q4 		$4.4K Hold
25
– – 0.01% 229
2025
Q3 		$3.5K Hold
25
– – 0.01% 239
2025
Q2 		$3.14K Hold
25
– – 0.01% 251
2025
Q1 		$3.42K Hold
25
– – 0.01% 251
2024
Q4 		$3.82K Buy
+25
New +$4.22K 0.02% 146

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Consultiva Wealth Management's BIIB Position: Q2 2026 in Review

Consultiva Wealth Management held its Biogen (BIIB) position steady in Q2 2026 at 25 shares worth $5.4K. The position accounts for 0.01% of the portfolio, ranked #244.

Consultiva Wealth Management first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Consultiva Wealth Management held 25 shares of Biogen worth $5.4K as of Q2 2026.
  • Consultiva Wealth Management left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Consultiva Wealth Management's portfolio in Q2 2026, its #244 holding.
  • Consultiva Wealth Management first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Consultiva Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.